The FDA's handling of proposed cancer drug defies compassion

By Winston Monroe
On Dec. 13, a trio of bipartisan Congressmen penned a letter calling for an investigation into the FDA's handling recently of a drug that was denied approval for terminal prostate cancer patients. The letter raises serious questions concerning unethical behavior at the FDA and should infuriate every American.

read more | digg story
 

0 comments so far.

Something to say?